These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mechanism of inhibitory action of eldecalcitol, an active vitamin D analog, on bone resorption in vivo. Takahashi N J Steroid Biochem Mol Biol; 2013 Jul; 136():171-4. PubMed ID: 23220095 [TBL] [Abstract][Full Text] [Related]
5. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines. Gniadecki R Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional profiling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. Lu J; Goldstein KM; Chen P; Huang S; Gelbert LM; Nagpal S J Invest Dermatol; 2005 Apr; 124(4):778-85. PubMed ID: 15816836 [TBL] [Abstract][Full Text] [Related]
7. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402 [TBL] [Abstract][Full Text] [Related]
8. Cytokines and growth factors in the regulation of bone remodeling. Mundy GR J Bone Miner Res; 1993 Dec; 8 Suppl 2():S505-10. PubMed ID: 7510095 [TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts. Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510 [TBL] [Abstract][Full Text] [Related]
10. IL-1 plays an important role in the bone metabolism under physiological conditions. Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512 [TBL] [Abstract][Full Text] [Related]
11. The effects of cytokines and growth factors on osteoblastic cells. Mundy GR; Boyce B; Hughes D; Wright K; Bonewald L; Dallas S; Harris S; Ghosh-Choudhury N; Chen D; Dunstan C Bone; 1995 Aug; 17(2 Suppl):71S-75S. PubMed ID: 8579902 [TBL] [Abstract][Full Text] [Related]
12. Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogs. Verstuyf A; Verlinden L; Segaert S; Van Etten E; Mathieu C; Bouillon R Miner Electrolyte Metab; 1999; 25(4-6):345-8. PubMed ID: 10681664 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D and bone. Suda T; Ueno Y; Fujii K; Shinki T J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524 [TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 increases the growth-promoting activity of autocrine epidermal growth factor receptor ligands in keratinocytes. Garach-Jehoshua O; Ravid A; Liberman UA; Koren R Endocrinology; 1999 Feb; 140(2):713-21. PubMed ID: 9927298 [TBL] [Abstract][Full Text] [Related]
15. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts. Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the cytokine pattern of porcine bone marrow-derived cells treated with 1alpha,25(OH)D. Sipos W; Duvigneau JC; Schmoll F; Exel B; Hofbauer G; Baravalle G; Hartl RT; Dobretsberger M; Pietschmann P J Vet Med A Physiol Pathol Clin Med; 2005 Oct; 52(8):382-7. PubMed ID: 16176565 [TBL] [Abstract][Full Text] [Related]
18. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs. Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory and hyperproliferative skin disease in mice that express elevated levels of the IL-1 receptor (type I) on epidermal keratinocytes. Evidence that IL-1-inducible secondary cytokines produced by keratinocytes in vivo can cause skin disease. Groves RW; Rauschmayr T; Nakamura K; Sarkar S; Williams IR; Kupper TS J Clin Invest; 1996 Jul; 98(2):336-44. PubMed ID: 8755642 [TBL] [Abstract][Full Text] [Related]
20. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]